Alexion Pharmaceuticals (ALXN) 10-K2008 FY Annual report

Filed: 23 Feb 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: AAA, adapt, Adienne, advice, agglutination, agglutinin, aggravate, allergic, Alligator, allocated, Amerisource, AmerisourceBergen, anaemia, aPL, APS, Arana, ARIAD, atypical, auction, bankruptcy, barrier, Bedrosian, Bergen, bifurcated, British, CAD, Camille, carryforward, catastrophic, chemotherapy, Claude, commonly, confidence, consumption, convenience, cooled, Corpoprate, corroboration, counterparty, creditworthy, DDD, deferral, dense, diminished, disagree, discomfort, distal, Duke, ease, edition, entry, episode, fetal, fine, Formulation, Francisco, FSP, glomerulonephropathy, greatest, Hemophilia, hierarchy, HUS, IgG, immunoglobulin, improper, Incode, ineffective, injunction, insight, insignificant, insolvent, instability, introduction, irrevocable, Japanese, jaundice, lapsing, Legend, libre, lifetime, Likewise, MA, maximize, membranoproliferative, microangiopathic, microangiopathy, mitigate, mitigated, mortality, MRC, multiorgan, mutation, Nicaise, NOL, nonderivative, nonexclusive, nonperformance, notional, Nurse, organizational, pallor, pharmacology, placenta, platelet, political, Pound, pre, pregnant, presidential, Proctor, proportion, recurring, refractory, reproduced, resorting, retroactively, robust, salary, satisfaction, sBLA, science, sensory, Shire, sixty, speculative, staffing, statutorily, sticking, Street, sum, Taligen, thrombotic, training, transparency, triad, Tulane, unadjusted, unapproved, unasserted, uncontrollable, uncontrolled, undistributed, unforeseen, Universite, unobservable, uremic, Wall, wilful, Wyeth, yen

Removed: activating, aggregated, alliance, antigen, APB, barry, Basel, blockade, Brigham, capture, cardiac, cardiovascular, category, Central, certified, Chairperson, choose, closely, cognitive, computer, Comtex, concurrently, consumer, deducted, dendritic, Deputy, developmental, devote, displayed, earlier, East, Electric, electronic, elevated, encompassing, equitable, eukaryotic, exchanged, exclusively, expensing, expression, extinguishment, extremely, finally, foregoing, GE, Gettysburg, graft, headed, Hoffmann, hyperreactivity, impede, indemnify, infarction, intrinsic, La, load, luke, lymphoid, mammalian, metabolic, migrate, million, modulation, month, Motola, Mundipharma, myocardial, Nancy, Nijmegen, noted, NRV, oral, ordinarily, peripheral, periphery, persistence, Ph, plc, producing, project, protocol, RAC, ranged, redemption, release, requirement, resting, revised, Roche, rodent, showed, signal, Softstrip, SPA, stroke, sublicense, subordinated, successively, suffering, suggest, suggested, targeting, terminal, transduction, trustee, underwriting, unimproved, unvested, utility, vested, whichever, Women, writing, xenotransplantation

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ALXN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-127471, 333-123828, 333-91265, 333-29617, 333-41397, 333-47645, 333-89343, 333-36738, 333-52886 and 333-59702) and Form S-8 (No. 333-146319, 333-139600, 333-123212, 333-119749, 333-24863, 333-52856, 333-69478, 333-71879, 333-71985, 333-106854 and 333-153612) of Alexion Pharmaceuticals, Inc. of our report dated February 23, 2009 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

Hartford, Connecticut

February 23, 2009